- HOME >
- For Researchers >
- Product Search >
- Search Result >
- #10337 Anti-Human Tenascin-C (EGF Like Domain) (4F10TT) Mouse IgG MoAb
Product Search
#10337 Anti-Human Tenascin-C (EGF Like Domain) (4F10TT) Mouse IgG MoAb
- Intended Use:
- Research reagents
- Application:
- WB, IHC
- Package Size1:
- 100 μg
- Package Size2:
- 10 μg
- Note on Application Abbreviations
- WB:Western Blotting
- IHC:Immunohistochemistry
※ The product indicated as "Research reagents" in the column Intended Use cannot be used
for diagnostic nor any medical purpose.
※ The datasheet listed on this page is sample only. Please refer to the datasheet
enclosed in the product purchased before use.
Product Overview
Product Overview
Product Code | 10337 |
---|---|
Product Name | Anti-Human Tenascin-C (EGF Like Domain) (4F10TT) Mouse IgG MoAb |
Intended Use | Research reagents |
Application | WB, IHC |
Species | Human |
Immunizing antigen | Purified human glioma tenascin-C |
Source | Mouse-Mouse hybridoma (Sp2/0×BALB/c mouse) |
Clone Name | 4F10TT |
Subclass | IgG1 |
Purification Method | Purified with Protein A |
Specificity | Specifically reacts with EGF like domain of all TN-C variants. Reacts with Mouse, Rat, Chicken and Rabbit. |
Package Form | Lyophilized product from PBS containing 1 % BSA and 0.05 %NaN3 |
Storage Condition | 2 - 8℃ |
Poisonous and Deleterious Substances | Applicable |
Cartagena | Not Applicable |
Package Size 1 | 100 μg |
Package Size 2 | 10 μg |
Remarks1 | The commercial use of products without our permission is prohibited. Please make sure to contact us and obtain permission. |
Product Description
Product Description
Tenascin-C (TN-C) is a component of the extracellular matrix (ECM) that has been shown to be involved in tissue interactions during fetal development and oncogenesis. It is glycoprotein consisting of six disulphide monomer isoforms being generated by alternative splicing. A high molecular weight variant that is generated by alternative splicing of RNAs of TN-C was found predominantly in breast, prostatic and colorectal cancers. The appearance of such a large TN-C isoform has been suggested to be of significance for tumour progression.
References
References
- Tenascin C in pancreatic cancer-associated fibroblasts enhances epithelial mesenchymal transition and is associated with resistance to immune checkpoint inhibitor. Furuhashi S et al. Am J Cancer Res. 2023 Nov 15;13(11):5641-5655.PMID: 38058842
- Tenascin-C as a potential marker for immunohistopathology of doxorubicin-induced cardiomyopathy. Nishikawa T et al. Eur Heart J Open. 2023 Oct 9;3(5):oead104.PMID: 37908440
- Tenascin-C in Tissue Repair after Myocardial Infarction in Humans. Matsui K et al. Int J Mol Sci. 2023 Jun 15;24(12):10184.PMID: 37373332/
- Expression Patterns of Microenvironmental Factors and Tenascin-C at the Invasive Front of Stage II and III Colorectal Cancer: Novel Tumor Prognostic Markers. Hashimoto M et al. Front Oncol. 2021 Aug 19;11:690816.PMID: 34490089
- Tenascin C in colorectal cancer stroma is a predictive marker for liver metastasis and is a potent target of miR-198 as identified by microRNA analysis. Murakami T et al. Br J Cancer. 2017 Oct 24;117(9):1360-1370.PMID: 29065427
- Cellular sources of tenascin-C in canine mammary carcinomas. Yoshimura H et al. Vet Pathol. 2015 Jan;52(1):92-6.PMID: 24565830
- Tenascin-C induces inflammatory mediators and matrix degradation in osteoarthritic cartilage. Patel L et al. BMC Musculoskelet Disord. 2011 Jul 15;12:164.PMID: 21762512
- Tenascin-C in chronic canine hepatitis: immunohistochemical localization and correlation with necro-inflammatory activity, fibrotic stage, and expression of alpha-smooth muscle actin, cytokeratin 7, and CD3+ cells. Mekonnen GA et al. Vet Pathol. 2007 Nov;44(6):803-13.PMID: 18039893
- Increased presence of stromal myofibroblasts and tenascin-C with malignant progression in canine mammary tumors. Yoshimura H et al. Vet Pathol. 2011 Jan;48(1):313-21.PMID: 20571146
Note: Retrieve by PMID number in displayed by abstract: http://www.ncbi.nlm.nih.gov
FAQ
FAQ
-
Q.What can be used for positive control?
-
A.Cancer cellline such as NB-1 can be used as the positive control.